Protein And MicroRNA Block Cellular Transition Vital To Metastasis
2/26/2011
Like a bounty hunter returning escapees to custody, a cancer-fighting gene converts organ cells that change into highly mobile stem cells back to their original, stationary state, researchers report online at Nature Cell Biology...
Discovery Of Killer Cells Has Potential For Targeted Cancer Therapies
2/26/2011
Scientists at Trinity College Dublin have made an important discovery concerning how fledgling cancer cells self-destruct, which has the potential of impacting on future cancer therapies...
On April 8th and 9th in Plantation, Florida, the Woman2Woman Breast Cancer Foundation will host its 2nd annual celebrity Golf Tournament and Pink Diamond Ball. Actor Hill Harper will host the Pink Diamond Ball and silent auction on April 9th. Founded in 2007, Woman2Woman founders Jacqueline R...
Breast Imaging Company, TechniScan, Signs Manufacturing Agreement With Texas Company
2/26/2011
TechniScan (OTC Bulletin Board: TSNI), a medical device company engaged in the development and commercialization of an automated 3D breast ultrasound imaging system, announced today that it has signed agreements for manufacturing and use of trademarks with Austin, Texas-based Womens3D...
Towards Customised Treatment Of Breast Cancer
2/26/2011
Breast cancer can develop very differently in different women. Researchers in Norway are improving breast cancer diagnostics and treatment by identifying the various tumour types. The objective is to find out as much as possible about the various tumour types so that each patient can receive precisely the right treatment at the right time. Women respond differently to available treatments...
University Of Nevada, Reno Teams With IMMY To Make New Life-Saving Blood Test
2/26/2011
A new, rapid blood test that could lead to early diagnosis and potentially save the lives of hundreds of thousands of people stricken with fungal meningitis, a leading cause of AIDS-related deaths in developing countries, is getting closer to market with a recent collaboration between the University of Nevada, Reno and Immuno-Mycologics (IMMY) in Oklahoma...
FDA Grants Full Approval For PROMACTA® (eltrombopag) For Treatment Of Rare Blood Disorder
2/26/2011
GlaxoSmithKline (NYSE: GSK) announced that the United States Food and Drug Administration (FDA) granted full approval for PROMACTA® (eltrombopag), an oral tablet that can raise platelet counts in patients with the rare blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy...
PSA Screening Drops Since Two Large Trial Results Were Published
2/26/2011
One large American health care network reports that PSA screening has gone down since a set of new guidelines were issued, as well as the publication of two large trials, says an article in the Journal of the National Cancer Institute. PSA screening should not occur for males older than 75 years, the US Preventive Services Task Force guidelines stated...
Radiation Significantly Raising Cancer Risk For Dialysis Patients
2/26/2011
High and frequent doses of radiation for dialysis patients, many of whom suffer from other illnesses and require radiation for diagnosis and treatments, put them at serious and significant risk of developing cancer, Italian scientists wrote in the Journal of the American Society of Nephrology...
Limit Red Meat To Reduce Risk Of Bowel Cancer, UK Advice
2/25/2011
People should limit their consumption of red and processed meat to no more than 70g a day to help reduce their risk of bowel cancer, the Department of Health for England announced on Friday. By red meat, they mean beef, lamb and pork plus minced meat or offal from the same animals. Examples of processed meat include ham, bacon, pâté, burgers, sausages, corned beef and salami...